药敏试验适用于任何有助于感染过程的有机体，以保证抗菌 化疗如果细菌病原体对抗菌剂的易感性不能根据细菌的特性进行预测 仅对该生物体进行体外抗菌药物敏感性试验，即对从动物疾病过程中分离出来的生物体进行体外抗菌药物敏感性试验 表明。多种实验室技术可用于测量细菌对抗菌剂的体外敏感性。临床的 以及实验室标准协会文件VET06《罕见分离细菌的药敏试验方法》 或从动物中分离出的挑剔细菌描述了标准的圆盘扩散法，以及标准的肉汤稀释法 （大稀释和微稀释）和琼脂稀释技术，用于从动物中分离不频繁或挑剔的细菌。 信息技术 还包括旨在标准化测试性能的程序。当前版本的性能、应用和局限性 描述了CLSI推荐的方法。本文档中的表格信息介绍了测试条件、QC建议、用于初级测试的代理， 和断点。在越来越多的化合物中，由于没有兽医特有的断点，人类 使用断点。随着更多针对兽医的信息变得可用，这些变化将被纳入未来的研究中 本文件的修订版。

Susceptibility testing is indicated for any organism that contributes to an infectious process warranting antimicrobial chemotherapy. If the susceptibility of a bacterial pathogen to antimicrobial agents cannot be predicted based on the identity of the organism alone, in vitro antimicrobial susceptibility testing of the organism isolated from the disease processes in animals is indicated.A variety of laboratory techniques can be used to measure the in vitro susceptibility of bacteria to antimicrobial agents. Clinical and Laboratory Standards Institute document VET06—Methods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animalsdescribes the standard disk diffusion method, as well as standard broth dilution (macrodilution and microdilution) and agar dilution techniques for infrequently isolated or fastidious bacteria from animals. It also includes procedures designed to standardize test performance. The performance, applications, and limitations of the current CLSI-recommended methods are described.The tabular information in this document presents test conditions, QC recommendations, agents to consider for primary testing, and breakpoints. In an increasing number of compounds for which veterinary-specific breakpoints are not available, human breakpoints are used. As more veterinary-specific information becomes available, these changes will be incorporated into future revisions of this document.